HCRT and narcolepsy-cataplexy syndrome: In a recent Danish study including a meta-analysis of seven studies the CSF-hypocretin-1 was low or undetectable in 69–100% (overall approximately 80%; 218/274) of patients with narcolepsy-cataplexy [9].